Early-stage or Locally Advanced HER2-positive Breast Cancer Clinical Trials in Shenyang, Liaoning

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer